Article
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
PloS one - 1 Jan 2016
Bruder Costa Juliana, Dufeu-Duchesne Tania, Leroy Vincent, Bertucci Inga, Bouvier-Alias Magali, Pouget Noelle, Brevot-Lutton Ophelie, Bourliere Marc, Zoulim Fabien, Plumas Joel, Aspord Caroline
Abstract excerpt
Pegylated interferon α-2a (Peg-IFN-α) represents a therapeutic alternative to the prolonged use of nucleos(t)ide analog (NA) in chronic hepatitis B (CHB) infection. The mechanisms leading to a positive clinical outcome remain unclear. As immune responses are critical for virus control, we investigated the effects of Peg-IFN-α on both innate and adaptive immunity, and related it to the clinical evolution. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
